drugset / Trial / NCT04557319
Safety and Pharmacokinetics of GNR-038 in Healthy Volunteers
Non-randomizedSequentialOpen-labelOther
Summary
It is an open-label dose-escalating study in sequential cohorts to assess safety and pharmacokinetics of GNR-038.
Timeline
- Start
- 2020-03-10
- Primary completion
- 2020-08-27
- Completion
- 2020-08-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | GNR-038 | Protein / enzyme biologic | 25 iu/kg | Intravenous |
| Subject | GNR-038 | Protein / enzyme biologic | 50 iu/kg | Intravenous |
| Subject | GNR-038 | Protein / enzyme biologic | 100 iu/kg | Intravenous |